Mellen Philip B, Walsh Thomas F, Herrington David M
Department of Internal Medicine, Section of General Medicine, Wake Forest University Health Sciences, Medical Center Blvd., Winston-Salem, NC 27157, USA.
Nutr Metab Cardiovasc Dis. 2008 May;18(4):283-90. doi: 10.1016/j.numecd.2006.12.008. Epub 2007 Apr 20.
Whole grain food sources have been associated with lowered risk of cardiovascular disease (CVD). Studies in recent years have strengthened this observation and elucidated potential mechanisms for this association. This study sought to quantitate the available observational evidence on whole grain intake and clinical cardiovascular events.
Seven prospective cohort studies with quantitative measures of dietary whole grains and clinical cardiovascular outcomes were identified from MEDLINE searches and a review of the literature. Based on event estimates adjusted for cardiovascular risk factors, greater whole grain intake (pooled average 2.5 servings/d vs. 0.2 servings/d) was associated with a 21% lower risk of CVD events [OR 0.79 (95% CI: 0.73-0.85)]. Similar estimates were noted for different CVD outcomes (heart disease, stroke, fatal CVD) and in sex-specific analyses. Conversely, refined grain intake was not associated with incident CVD events [1.07 (0.94-1.22)].
There is a consistent, inverse association between dietary whole grains and incident cardiovascular disease in epidemiological cohort studies. In light of this evidence, policy-makers, scientists, and clinicians should redouble efforts to incorporate clear messages on the beneficial effects of whole grains into public health and clinical practice endeavors.
全谷物食物来源与心血管疾病(CVD)风险降低相关。近年来的研究强化了这一观察结果,并阐明了这种关联的潜在机制。本研究旨在量化关于全谷物摄入量与临床心血管事件的现有观察证据。
通过对MEDLINE数据库的检索及文献综述,确定了七项对膳食全谷物和临床心血管结局进行定量测量的前瞻性队列研究。基于对心血管危险因素进行校正后的事件估计值,较高的全谷物摄入量(合并平均每日2.5份 vs. 0.2份)与CVD事件风险降低21%相关[比值比(OR)0.79(95%置信区间:0.73 - 0.85)]。对于不同的CVD结局(心脏病、中风、致命性CVD)以及按性别进行的分析,也得到了类似的估计值。相反,精制谷物摄入量与新发CVD事件无关[1.07(0.94 - 1.22)]。
在流行病学队列研究中,膳食全谷物与新发心血管疾病之间存在一致的负相关关系。鉴于这一证据,政策制定者、科学家和临床医生应加倍努力,将关于全谷物有益作用的明确信息纳入公共卫生和临床实践工作中。